Nozohaem®
– a new unique treatment of nosebleeds
Nosebleeds
By asking a population one knows that about 60 % of all people have had nosebleeds.
Recurrent bleedings every year are noted by 4 %. A bleeding from the nose (epistaxis)
usually comes from the anterior part of the middle wall of the nose called Kiesselbach
area.
Traditional treatment
In principle there are two different ways to treat a bleeding nose, either cauterize
and destroy the bleeding vessel when it is possible to locate it or when it is not
use different kinds of tampons that are pressed into the nose with the intention
to arrest the blood fl ow through the damaged vessel. Both methods needs participation
of a doctor and tampons in the nose are painful to the patient .
Nozohaem®, a better alternative
As often has happened in the history of medicine and pharmacology a failure generates
a successful product. The idea behind Nozohaem goes back to a randomized, controlled
clinical study in the ENT Clinic at Sahlgrenska University Hospital, Gothenburg
Sweden. The purpose was to fi nd a better way to stop nosebleed. A comparison was
made between 10 percent fi brinolytic inhibitor tranexamic acid gel and placebo,
a 10 percent solution of glycine, the least complex of the amino acids. When breaking
the code the placebo proved to be more effective than the tranexamic gel. Of course
the disappointing study did not result in any new product at that time. Professor
Björn Petruson, ENT-specialist at Sahlgrenska University Hospital, and the man behind
Nozohaem, made research on nosebleeds during six years in the 1960s and 70s.
|
|
|